Laboratory for Molecular Diagnostics
Center for Nephrology and Metabolic Disorders
Moldiag Diseases Genes Support Contact

Aceruloplasminemia/Hypoceruloplasminemia

Aceruloplasminemia and Hypoceruloplasminemia are hereditary disorders including copper and iron metabolism. The disorders are caused by mutations of the CP (ceruloplasmin) gene, which result in copper storage in different tissues characterized clinically by systemic hemosiderosis, diabetes mellitus, pigment degeneration of the retina, and neurologic abnormalities. Depending on the nature of the mutation and the allele dosage dominant and recessive as well as hypo- and acaeruloplasminemia may be discriminated. Heterozygous mutations usually result in hypoaceruloplasminemia while aceruloplasminemia is a recessive disorder.

Systematic

Hereditary disorders protein metabolism
Aceruloplasminemia/Hypoceruloplasminemia
CP
Congenital analbuminemia

References:

1.

Morita H et al. (1992) [A case of ceruloplasmin deficiency which showed dementia, ataxia and iron deposition in the brain].

[^]
2.

Hahn P et al. (2004) Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration.

[^]
3.

Krawczak M et al. (1991) Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

[^]
4.

Miyajima H et al. (1987) Familial apoceruloplasmin deficiency associated with blepharospasm and retinal degeneration.

[^]
5.

Lee GR et al. (1968) Iron metabolism in copper-deficient swine.

[^]
6.

Osaki S et al. (1966) The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum.

[^]
7.

Yoshida K et al. (1995) A mutation in the ceruloplasmin gene is associated with systemic hemosiderosis in humans.

[^]
8.

Harris ZL et al. (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.

[^]
9.

Okamoto N et al. (1996) Hereditary ceruloplasmin deficiency with hemosiderosis.

[^]
10.

Takahashi Y et al. (1996) Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease.

[^]
11.

Roy CN et al. (2001) Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers.

[^]
12.

Edwards CQ et al. (1979) Hereditary hypoceruloplasminemia.

[^]
13.

None (1980) Pharmacology of blepharospasm-oromandibular dystonia syndrome.

[^]
14.

Tanner CM et al. (1982) Meige disease: acute and chronic cholinergic effects.

[^]
15.

Morita H et al. (1995) Hereditary ceruloplasmin deficiency with hemosiderosis: a clinicopathological study of a Japanese family.

[^]
16.

Miyajima H et al. (1997) Use of desferrioxamine in the treatment of aceruloplasminemia.

[^]
17.

Orphanet article

Orphanet ID 48818 [^]
18.

OMIM.ORG article

Omim 604290 [^]
Update: May 9, 2019
Copyright © 2005-2020 by Center for Nephrology and Metabolic Disorders, Dr. Mato Nagel, MD
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Germany, Tel.: +49-3576-287922, Fax: +49-3576-287944
Sitemap | Webmail | Disclaimer | Privacy Issues